Spectra Page
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Spectra Page for site: > Lys1162  - A2M (human)

PeptideReferences 
ALLAYAFALAGNQDKR 8, 11 39561 View spectrum 39615 View spectrum 41029 View spectrum
ALLAYAFALAGNQDK 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 40572 View spectrum 40619 View spectrum 40640 View spectrum 40665 View spectrum 40684 View spectrum 40707 View spectrum 40754 View spectrum 41139 View spectrum 41193 View spectrum 41291 View spectrum 41336 View spectrum 41343 View spectrum 41387 View spectrum 41390 View spectrum 41431 View spectrum 41442 View spectrum 41474 View spectrum 41478 View spectrum 41487 View spectrum 41516 View spectrum 41532 View spectrum 41558 View spectrum 41580 View spectrum 41599 View spectrum 41621 View spectrum 41643 View spectrum 41665 View spectrum 41687 View spectrum 41709 View spectrum 41840 View spectrum 41859 View spectrum 41901 View spectrum 41907 View spectrum 41910 View spectrum 41918 View spectrum 41935 View spectrum 41940 View spectrum 41945 View spectrum 41956 View spectrum 41989 View spectrum 42000 View spectrum 42026 View spectrum 42040 View spectrum 42212 View spectrum 42221 View spectrum 42235 View spectrum 42245 View spectrum 42332 View spectrum 42343 View spectrum 42557 View spectrum 42586 View spectrum 42605 View spectrum 42613 View spectrum 42618 View spectrum 42635 View spectrum 42653 View spectrum 42660 View spectrum 42660 View spectrum 42679 View spectrum 42705 View spectrum 42706 View spectrum 42708 View spectrum 42748 View spectrum 43724 View spectrum 43744 View spectrum 43761 View spectrum 43779 View spectrum 43788 View spectrum 43797 View spectrum 43808 View spectrum 43830 View spectrum 43831 View spectrum 43852 View spectrum 44123 View spectrum 44129 View spectrum 44172 View spectrum 44223 View spectrum 44279 View spectrum 44367 View spectrum 44378 View spectrum 44412 View spectrum 44421 View spectrum 44990 View spectrum 44993 View spectrum 45042 View spectrum 45124 View spectrum 45136 View spectrum 48700 View spectrum 48720 View spectrum 48752 View spectrum 48780 View spectrum 48811 View spectrum 48828 View spectrum

References 

1

Rikova K (2013) CST Curation Set: 20218; Year: 2013; Biosample/Treatment: cell line, H2342, H2073, Lou-NH91, HCC15, H1703; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

2

Rikova K (2013) CST Curation Set: 20219; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

3

Rikova K (2013) CST Curation Set: 20220; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

4

Rikova K (2013) CST Curation Set: 20221; Year: 2013; Biosample/Treatment: cell line, H838, DMS153, H2073, H209, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

5

Rikova K (2013) CST Curation Set: 20213; Year: 2013; Biosample/Treatment: cell line, H1417, DMS79, H128, H209, H524; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

6

Rikova K (2013) CST Curation Set: 20214; Year: 2013; Biosample/Treatment: cell line, DMS53, H526, H69, H82, H446; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

7

Rikova K (2013) CST Curation Set: 20215; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

8

Rikova K (2013) CST Curation Set: 20216; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

9

Rikova K (2013) CST Curation Set: 20217; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

10

Rikova K (2013) CST Curation Set: 18855; Year: 2013; Biosample/Treatment: cell line, H3122/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

11

Rikova K (2013) CST Curation Set: 18854; Year: 2013; Biosample/Treatment: cell line, H2228/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

12

Rikova K (2012) CST Curation Set: 16030; Year: 2012; Biosample/Treatment: cell line, MKN45/crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

13

Rikova K (2012) CST Curation Set: 16031; Year: 2012; Biosample/Treatment: cell line, H3255/iressa; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK

14

Rikova K (2012) CST Curation Set: 16032; Year: 2012; Biosample/Treatment: cell line, H1703/gleevec; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK